The company provides digital infrastructure for Web3, blockchain, and online gaming, earning revenue through software development, validator node operations, and fintech services across international jurisdictions.
The company operates in a highly fragmented and speculative sector without proprietary technology or scale advantages that manifest in the financials. While it claims a Web3 ecosystem, the lack of durable return on capital or pricing power suggests no structural competitive advantage.
Capital has primarily been used to fund the merger and settle insolvency obligations. Recent activities involve aggressive equity issuance and expansion into diverse fintech ventures, but these have yet to demonstrate a track record of value creation for minority shareholders.
Five years later, the capital has evaporated as the aggressive equity issuance used to fund speculative fintech ventures failed to generate a return above the cost of capital. The complex merger accounting and large goodwill balances eventually led to massive impairments when the 'Web3 ecosystem' failed to monetize. The company's history of insolvency repeated itself as related-party transactions drained cash reserves, leaving minority shareholders with a diluted stake in a shell that never established a viable business model beyond promotional rhetoric.
RichFakir rates String Metaverse Ltd's business quality as mediocre — 53/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, String Metaverse Ltd is trading about 28% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on String Metaverse Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of String Metaverse Ltd's fair value is about ₹9 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →